ES2214738T3 - Formulaciones parenterales que comprenden 10-hidroxi-10,11-tetrahidrocarbamazepina, agua y glucosa. - Google Patents

Formulaciones parenterales que comprenden 10-hidroxi-10,11-tetrahidrocarbamazepina, agua y glucosa.

Info

Publication number
ES2214738T3
ES2214738T3 ES98950110T ES98950110T ES2214738T3 ES 2214738 T3 ES2214738 T3 ES 2214738T3 ES 98950110 T ES98950110 T ES 98950110T ES 98950110 T ES98950110 T ES 98950110T ES 2214738 T3 ES2214738 T3 ES 2214738T3
Authority
ES
Spain
Prior art keywords
glucose
parenteral
water
compound
formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES98950110T
Other languages
English (en)
Spanish (es)
Inventor
Peter Van Hoogevest
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Application granted granted Critical
Publication of ES2214738T3 publication Critical patent/ES2214738T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
ES98950110T 1997-10-09 1998-10-07 Formulaciones parenterales que comprenden 10-hidroxi-10,11-tetrahidrocarbamazepina, agua y glucosa. Expired - Lifetime ES2214738T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9721497.7A GB9721497D0 (en) 1997-10-09 1997-10-09 Organic compounds
GB9721497 1997-10-09

Publications (1)

Publication Number Publication Date
ES2214738T3 true ES2214738T3 (es) 2004-09-16

Family

ID=10820342

Family Applications (1)

Application Number Title Priority Date Filing Date
ES98950110T Expired - Lifetime ES2214738T3 (es) 1997-10-09 1998-10-07 Formulaciones parenterales que comprenden 10-hidroxi-10,11-tetrahidrocarbamazepina, agua y glucosa.

Country Status (31)

Country Link
US (2) US6316417B1 (enExample)
EP (1) EP1033988B1 (enExample)
JP (2) JP2001519395A (enExample)
KR (1) KR100760326B1 (enExample)
CN (1) CN1210032C (enExample)
AR (1) AR015465A1 (enExample)
AT (1) ATE257383T1 (enExample)
AU (1) AU748034B2 (enExample)
BR (1) BR9812861A (enExample)
CA (1) CA2304661C (enExample)
CO (2) CO4950520A1 (enExample)
CZ (1) CZ298900B6 (enExample)
DE (1) DE69821024T2 (enExample)
DK (1) DK1033988T3 (enExample)
ES (1) ES2214738T3 (enExample)
GB (1) GB9721497D0 (enExample)
HU (1) HU226106B1 (enExample)
ID (1) ID24134A (enExample)
IL (1) IL135123A0 (enExample)
MY (1) MY122129A (enExample)
NO (1) NO327263B1 (enExample)
NZ (1) NZ503526A (enExample)
PE (1) PE121998A1 (enExample)
PL (1) PL192287B1 (enExample)
PT (1) PT1033988E (enExample)
RU (1) RU2242231C2 (enExample)
SK (1) SK286253B6 (enExample)
TR (1) TR200000870T2 (enExample)
TW (1) TW584563B (enExample)
WO (1) WO1999018966A1 (enExample)
ZA (1) ZA989183B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0507298D0 (en) 2005-04-11 2005-05-18 Novartis Ag Organic compounds
EP1928464B1 (en) * 2005-09-30 2014-05-14 Lundbeck Inc. Novel parenteral carbamazepine formulation
US20100204178A1 (en) 2006-10-02 2010-08-12 James Cloyd Novel parenteral carbamazepine formulation
CA2635797C (en) * 2006-02-09 2015-03-31 Macusight, Inc. Stable formulations, and methods of their preparation and use
US8372431B2 (en) 2007-10-26 2013-02-12 Bial-Portela & C.A., S.A. Pharmaceutical composition comprising licarbazepine acetate
CN101711739B (zh) * 2008-10-08 2012-07-04 中国人民解放军军事医学科学院毒物药物研究所 卡马西平的口服药物组合物
CN105726466A (zh) * 2014-12-10 2016-07-06 辽宁药联制药有限公司 一种奥卡西平注射剂及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5202311A (en) * 1988-08-19 1993-04-13 Children's Medical Center Corporation Stabilized fgf composition
EP0435826A1 (de) * 1989-12-27 1991-07-03 Ciba-Geigy Ag Intravenöse Lösungen für Status Epilepticus
ES2081965T3 (es) * 1989-12-27 1996-03-16 Ciba Geigy Ag Dispositivo para homogenizar la distribuccion no homogenea de la luz de un haz de rayos laser.
US5284662A (en) * 1990-10-01 1994-02-08 Ciba-Geigy Corp. Oral osmotic system for slightly soluble active agents
RU2020972C1 (ru) * 1991-02-07 1994-10-15 Мегдятов Рашид Салехович Способ лечения невралгии тройничного нерва
US5231089A (en) * 1991-12-02 1993-07-27 University Of Florida Method of improving oral bioavailability of carbamazepine
FR2702148B1 (fr) * 1993-03-05 1995-04-07 Rhone Poulenc Rorer Sa Application d'anticonvulsivants dans le traitement du neuro-sida.
US5472714A (en) * 1993-09-08 1995-12-05 Ciba-Geigy Corporation Double-layered oxcarbazepine tablets
US5466683A (en) * 1994-08-25 1995-11-14 Teva Pharmaceutical Industries Ltd. Water-soluble analogs of carbamazepine

Also Published As

Publication number Publication date
PL339446A1 (en) 2000-12-18
KR100760326B1 (ko) 2007-09-20
HUP0004362A2 (hu) 2001-08-28
KR20010072533A (ko) 2001-07-31
CO5090854A1 (es) 2001-10-30
AU9629898A (en) 1999-05-03
TR200000870T2 (tr) 2000-10-23
TW584563B (en) 2004-04-21
ID24134A (id) 2000-07-06
CN1274286A (zh) 2000-11-22
NZ503526A (en) 2003-01-31
PL192287B1 (pl) 2006-09-29
NO20001730L (no) 2000-04-04
US6316417B1 (en) 2001-11-13
EP1033988A1 (en) 2000-09-13
AR015465A1 (es) 2001-05-02
DE69821024D1 (de) 2004-02-12
CO4950520A1 (es) 2000-09-01
NO20001730D0 (no) 2000-04-04
MY122129A (en) 2006-03-31
HUP0004362A3 (en) 2006-06-28
PT1033988E (pt) 2004-05-31
WO1999018966A1 (en) 1999-04-22
NO327263B1 (no) 2009-05-25
CN1210032C (zh) 2005-07-13
US20020055503A1 (en) 2002-05-09
GB9721497D0 (en) 1997-12-10
EP1033988B1 (en) 2004-01-07
DE69821024T2 (de) 2004-10-28
CA2304661A1 (en) 1999-04-22
SK286253B6 (sk) 2008-06-06
CA2304661C (en) 2007-12-11
CZ298900B6 (cs) 2008-03-05
US6458770B1 (en) 2002-10-01
ATE257383T1 (de) 2004-01-15
DK1033988T3 (da) 2004-04-13
HU226106B1 (en) 2008-04-28
BR9812861A (pt) 2000-08-08
RU2242231C2 (ru) 2004-12-20
JP2005281314A (ja) 2005-10-13
JP2001519395A (ja) 2001-10-23
HK1031824A1 (en) 2001-06-29
IL135123A0 (en) 2001-05-20
AU748034B2 (en) 2002-05-30
CZ20001279A3 (cs) 2000-07-12
PE121998A1 (es) 1999-12-08
SK5052000A3 (en) 2000-12-11
ZA989183B (en) 1999-04-09

Similar Documents

Publication Publication Date Title
JP6812094B2 (ja) ノルエピネフリンの注射剤形
ES2222895T3 (es) Composiciones de dihidroergotamina de alta potencia.
ES2985740T3 (es) Forma de dosificación de perfusión
ES2537294T5 (es) Solución de gemcitabina lista para ser infundida
ES2791349T3 (es) Formulación acuosa que comprende paracetamol e ibuprofeno
PT1368019E (pt) Formulação de esmolol
EP4288078A1 (en) Oxytocin ready to infuse dosage form
HRP20020636A2 (en) Pharmaceutical composition comprising pemetrexed with monothioglycerol l-cystein or thioglycolic acid
ES2272720T3 (es) Formulacion de esmolol.
ES2214738T3 (es) Formulaciones parenterales que comprenden 10-hidroxi-10,11-tetrahidrocarbamazepina, agua y glucosa.
ES2399629T3 (es) Sistema de acondicionamiento para composiciones farmacéuticas y kit para administración intravenosa
BRPI0616127A2 (pt) formulação de argatroban
ES2198424T3 (es) Soluciones inyectables listas para el empleo que contienen doxorrubicina.
ES2277397T3 (es) Formas liquidas de administracion de productos farmaceuticos que contienen oxazafosforina.
US20190336443A1 (en) Ready-To-Use Liquid Parenteral Formulations Of Ribavirin
ES2823281T3 (es) Forma de dosificación del fármaco alcaloide vinca
US11642358B1 (en) Stable pharmaceutical formulation
ES3036668T3 (en) Pharmaceutical compositions for parenteral administration comprising ibuprofen and a phosphate buffer
HK1031824B (en) Parenteral formulations comprising 10-hydroxy-10, 11-tetrahydrocarbamazepine, water and glucose
MXPA00003413A (en) Parenteral formulations comprising carbamazepine or its derivatives
JPH10287569A (ja) アシクロビル又はその塩の輸液型キット注射剤
JPH11124329A (ja) カルボプラチン水溶液製剤
US20160081972A1 (en) Parenteral dosage form of amiodarone